Venetoclax (ABT-199, GDC-0199)
 
       商品编号:
        
         TL0985
         
        
        
       
       
       
      
         
          
备注:
 如需更大包装,请联系销售人员,大包装有极大的折扣优惠!
          
       
       
       
       
        
        
详细介绍
 
       
              
          | l  基本信息 | 
| 产品名称 | Venetoclax | 
| 一般描述 | Venetoclax is a Bcl-2-selective inhibitor. | 
| 别 称 | ABT-199, GDC-0199 | 
| 纯 度 | ≥99.0%(HPLC) | CAS NO. | 1257044-40-8 | 
| 分子式 | C45H50ClN7O7S | 分子量 | 868.44 | 
| 适用范围 | 生物试剂,适用于细胞培养等 | 
| l  理化信息 | 
| 外 观 | 浅黄色至黄色或橙黄色粉末 | 
| 溶解性(25℃) | DMSO | ≥50mg/mL(warmed) | 
| 乙醇 | Insoluble | 
| 水 | Insoluble | 
| l  生物学信息 | 
| 生物活性/药理作用 | Venetoclax is an orally bioavailable, selective small molecule inhibitor of the anti-apoptotic protein Bcl-2, with potential antineoplastic activity. Venetoclax mimics BH3-only proteins, the native ligands of Bcl-2 and apoptosis activators, by binding to the hydrophobic groove of Bcl-2 proteins thereby repressing Bcl-2 activity and restoring apoptotic processes in tumor cells. Bcl-2 protein is overexpressed in some cancers and plays an important role in the regulation of apoptosis; its  is associated with increased drug resistance and tumor cell survival. Compared to the Bcl-2 inhibitor navitoclax, this agent does not
  inhibit bcl-XL and does not cause bcl-XL-mediated thrombocytopenia. Venetoclax is a Bcl-2-selective inhibitor with Ki of <0.01 nM in cell-free assays, >4800-fold more selective versus Bcl-xL and Bcl-w, and no activity to Mcl-1. | 
| l  存储 | 
| 存储温度 | -20℃ | 
| l  注意事项及免责声明 | 
| 本产品仅用于实验研究,不得作为药物使用,不得用于家用或其它用途。 | 
| l  参考文献 | 
| 1.    http://www.drugbank.ca 2.    https://ncit.nci.nih.gov 3.    https://www.ncbi.nlm.nih.gov |